Comishen Kyle J, Bhatt Meha, Yeung Katie, Irfan Jehan, Zia Ayesha, Sidonio Robert F, James Paula
School of Medicine, Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada.
Division of Hematology/Oncology, The University of Texas Southwestern Children's Medical Center, Dallas, Texas.
J Thromb Haemost. 2025 Mar;23(3):863-876. doi: 10.1016/j.jtha.2024.11.014. Epub 2024 Nov 30.
Heavy menstrual bleeding (HMB) is excessive menstrual blood loss that interferes with an individual's quality of life. Many individuals with HMB are inadequately managed by health care providers.
This systematic review aims to provide a comprehensive summary of the etiologies and diagnosis of HMB while calculating the prevalence of underlying causes among premenopausal patients and quantifying the test accuracy of diagnostic strategies.
MEDLINE, EMBASE, the Cochrane Library, and Web of Science were searched since inception to include studies investigating the prevalence of underlying etiology and diagnostic accuracy of investigations for HMB. The primary outcome was the prevalence of the causes of HMB, secondary outcome included the prevalence of etiology by age. Meta-analyses were conducted via random-effects model.
In total, 53 studies were included. Forty-five studies included data on the prevalence of underlying HMB etiology, totaling 41 541 patients. The overall prevalence of bleeding disorders was 30% (95% CI, 14-46); von Willebrand disease, 8% (95% CI, 7-10); platelet function defect, 9% (95% CI, 7-12); abnormal thyroid, 3% (95% CI, 0-6); and polycystic ovarian syndrome, 8% (95% CI, 4-12). Subgroup analysis showed bleeding disorders were prevalent in 16% (95% CI, -8 to 41) of adults with HMB but in 39% (95% CI 18-60) of adolescents with HMB.
Many diagnoses were associated with bleeding disorders and, therefore, warrant investigation when assessing a patient with HMB of unknown etiology. The causes are likely age dependent and should be considered when diagnosing HMB.
月经过多(HMB)是指月经量过多,影响个体生活质量。许多患有HMB的个体未得到医疗保健提供者的充分管理。
本系统评价旨在全面总结HMB的病因和诊断,同时计算绝经前患者潜在病因的患病率,并量化诊断策略的检测准确性。
自数据库建立以来,检索了MEDLINE、EMBASE、Cochrane图书馆和科学网,纳入研究HMB潜在病因患病率及诊断准确性的研究。主要结局是HMB病因的患病率,次要结局包括按年龄划分的病因患病率。通过随机效应模型进行荟萃分析。
共纳入53项研究。45项研究纳入了HMB潜在病因患病率的数据,共计41541名患者。出血性疾病的总体患病率为30%(95%CI,14-46);血管性血友病,8%(95%CI,7-10);血小板功能缺陷,9%(95%CI,7-12);甲状腺异常,3%(95%CI,0-6);多囊卵巢综合征,8%(95%CI,4-12)。亚组分析显示,出血性疾病在16%(95%CI,-8至41)的成年HMB患者中普遍存在,但在39%(95%CI,18-60)的青少年HMB患者中普遍存在。
许多诊断与出血性疾病相关,因此,在评估病因不明的HMB患者时值得进行调查。病因可能与年龄有关,在诊断HMB时应予以考虑。